AlloVir Inc
About
AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John R. Wilson, and Ann M. Leen in August 2013 and is headquartered in Waltham, MA.
Growth
AlloVir is currently at a growth stage where it is focused on advancing its Phase 3 clinical development program for Posoleucel, an allogeneic virus-specific T cell therapy. The company is transitioning from a research and development phase to a critical stage of testing and data collection to potentially bring its therapy to market. This phase marks AlloVir's progression towards becoming a key player in the field of T cell therapies for severe viral diseases.
Achievements
AlloVir has achieved significant milestones in the development of its allogeneic, virus-specific T cell therapy platform. The company has successfully targeted 11 different devastating viruses for treatment or prevention, showcasing the broad potential of its technology. Furthermore, AlloVir's proprietary platform has shown promising results in restoring immunity in patients with T cell deficiencies, positioning the company as a leader in the field of T cell therapy development.
Case Studies
While specific case studies may not be provided in the company description, AlloVir's focus on developing off-the-shelf virus-specific T cell therapies and restoring immunity in patients with T cell deficiencies showcases the potential impact of its technology. By targeting a wide range of devastating viruses and offering alternative treatment options for patients at risk of severe viral diseases, AlloVir's case studies, when available, are expected to demonstrate the efficacy and versatility of its T cell therapy platform.
Key Events
In the last 12 months, AlloVir has been actively involved in advancing its Phase 3 clinical development program for Posoleucel, a key event that signifies the company's progress towards potentially bringing its allogeneic virus-specific T cell therapy to market. Additionally, AlloVir's focus on developing off-the-shelf virus-specific T cell therapies, as highlighted in recent news updates, showcases the company's commitment to innovation and patient-centric advancements in the field of T cell therapies. These key events underscore AlloVir's dedication to redefining treatment options for severe viral diseases.
Socials
Website
Founded
-
Operating Status
Active
Industry
Health Care/Life Sciences
headquarters
Address
1100 Winter Street Waltham Massachusetts 02451 United States...
Country
United States
Employees
112
Key People
Juan F. Vera (Director & Chief Product Development Officer)
Jeffrey S. Bornstein (Independent Non-Executive Director)
Ann M. Leen (Chief Scientific Officer)
Juan F. Vera (Director)
Revenue
-
Operating Income
Stock Price
$0.775
Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC
Similar Companies
Welcome to AiDOOS Wiki
AiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.
AlloVir Inc
-
Website
-
Founded
-
-
Industry
Health Care/Life Sciences
-
Address
1100 Winter Street Waltham Massachusetts 02451 United States...
-
Country
United States
-
Number of employees
112+
-
Revenue
-
About AlloVir Inc
AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John R. Wilson, and Ann M. Leen in August 2013 and is headquartered in Waltham, MA.
Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC
